Articles tagged with 'Company' | Bayer

New issue of two tranches with a non-call period of 5.25 and 8.25 years, respectively, combined with a tender offer for two of Bayer’s existing hybrid bonds

Leverkusen, August 21, 2023 – The Supervisory Board of Bayer AG has unanimously appointed Heike Prinz to Bayer’s Board of Management effective September 1, 2023. She will become the company’s Chief Talent Officer and Labor Director. This follows the ...

Group sales fall by 8.2 percent (Fx & portfolio adj.) to 11.044 billion euros / EBITDA before special items: 2.527 billion euros (minus 24.5 percent) / Crop Science business down significantly, mainly due to sharp decline in glyphosate volumes and pr...

Leverkusen, July 24, 2023 – The Bayer Group adjusted its full-year outlook for 2023 downward on Monday, mainly due to a significant further decline in sales of glyphosate-based products.For full-year 2023, Bayer now anticipates sales of between 48.5 ...

Issuance consisted of three tranches with maturities between 3.25 and 10 years and was substantially oversubscribed

Group sales stable at 14.389 billion euros (Fx & portfolio adj. minus 1.1 percent)o   Accelerated normalization in glyphosate business – good price dynamics in other Crop Science unitso   New Pharmaceuticals products deliver strong growth – headwinds...

Generating 1,400 GWh annually, Idaho Renewable Energy Agreement Underscores Bayer's Global Commitment to Sustainability and Rural Communities

Substantial sales and earnings growth in 2022 / Dividend of 2.40 euros per share proposed – up 20 percent / Baumann to retire at the end of May – Bill Anderson designated as his successor

Company was part of delegation led by German Vice-Chancellor Robert Habeck to Kyiv this week / Bayer underscores commitment to Ukraine and to help rebuild the economy / Investment adds to earlier 200 million euro spending for seed production and mult...

Experts from different academic disciplines to provide broad external perspective and guidance on complex bioethical questions related to emerging life science technologies / Bayer is committed to using new technologies in ethically responsible manne...

Holistic approach to improve water use and quality across the entire value chain and contribute to an impactful change / Integration of water stewardship in business and investment decisions / Shaping a water-resilient agriculture system with key con...

Group sales increase 8.7 percent (Fx & portfolio adj.) to 50.739 billion euros / EBITDA before special items rises 20.9 percent to 13.513 billion euros, largely driven by exceptionally strong performance at Crop Science / Pharmaceuticals increases sa...

Agnes Binagwaho, Dante Pesce and Jeffrey Ubben appointed to independent Sustainability Council / New personnel enhance the council’s subject matter expertise in key focus areas such as access to medicine, human rights and sustainable finance / Brauli...

Bayer provides 1 million euros for immediate aid to Türkiye via the disaster relief organizations Red Crescent and Ahbap as well as 200.000 euros to Syria via the German Red Cross / A global employee donation campaign for both Türkiye and Syria will ...

The Professor at the Institute of Organic Chemistry at the University of Münster receives the award in recognition of his groundbreaking work / Professor Antje Boetius, Director of the Alfred Wegener Institute (AWI) in Bremerhaven, is presented with ...

Bayer receives the highest CDP score for its activities and transparency in climate change / This rating confirms the company’s high commitment to sustainability / A record-breaking 18,700 companies disclosed data on environmental impacts, risks, and...

The Bayer Science Collaboration Explorer makes contract-based scientific collaborations with universities, public research institutions and individuals publicly available in the U.S.  / Aim of the database is to foster public trust in science by show...

Financial support for the Chernihiv Medical Center of Modern Oncology and the Romodanov Institute of Neurosurgery / The donation goes to UNITED24, the main platform for charitable donations to reconstruct Ukraine  ...

Chairman of the Board of Management / Chief Financial Officer

Group sales increase by 5.7 percent (Fx & portfolio adj.) to 11.281 billion euros  / EBITDA before special items rises by 17.3 percent to 2.451 billion euros / Crop Science achieves strong sales gains – sales also up at Pharmaceuticals and Consumer H...

Business to continue operations as an independent company called Envu

Succeeds Fei-Fei Li, who stepped down at the end of August

Leverkusen, August 12, 2022 – Bayer welcomes the dismissal of BASF’s claims by the arbitral tribunal. Bayer provided adequate information on the cost structure of the seeds businesses acquired by BASF in August 2018 and did not breach any contractual...

Group sales increase by 9.6 percent (Fx & portfolio adj.) to 12.819 billion euros / EBITDA before special items rises by 30.0 percent to 3.349 billion euros / Crop Science and Consumer Health achieve strong sales and earnings growth / Pharmaceuticals...

Investment of approximately 275 million euros in the world’s first learning pharmaceutical production facility / 70 percent lower CO2 emissions than conventional plants

Group sales grow by 14.3 percent (Fx & portfolio adj.) to 14.639 billion euros / EBITDA before special items increases by 27.5 percent to 5.251 billion euros / Substantial sales and earnings growth at Crop Science and Consumer Health / Sales up sligh...

Chairman of the Board of Management

Chairman of the Supervisory Board of Bayer AG

Operationally and strategically successful in 2021 / Dividend of 2.00 euros per share proposed / Very successful start to 2022

New issue of two tranches with a non-call period of 5.5 and 8.5 years, respectively, combined with a tender offer for one of Bayer’s existing hybrid bonds